http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20130014646-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1c771726e89b709f93b922aba311e8a0 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-0066 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-0068 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-0071 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-412 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-0059 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-1455 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-14532 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-0064 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-0075 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N21-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-441 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N- http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N21-64 |
| filingDate | 2004-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c89fec58401b2000fb03da74fd31c7af http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ccf9db4103059ea989466aa496302746 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_29d1a1de0cb272a61c10563e6e3d49b8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9e53e8fa948e7f450484b6175f8472ab |
| publicationDate | 2013-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20130014646-A |
| titleOfInvention | Method of Determination of Glycosylated End Product or Disease Status Using Tissue Fluorescence |
| abstract | The present invention relates to a method of determining the measurement of a tissue state of an individual (eg, a non-enzymatic glycation end product or disease state). After the tissue portion of the subject is illuminated by the excitation light, light emitted by the tissue is detected due to the fluorescence of the compound having the tissue responding to the excitation light. The detected light may be coupled to a model that associates fluorescence with the measurement of tissue status to measure tissue status. The invention may include single wavelength excitation light, scanning of excitation light (lighting tissue at multiple wavelengths), detection at a single wavelength, scanning of detection wavelengths (detecting light emitted at multiple wavelengths), and combinations thereof. have. The present invention may also include a correction technique that reduces error determination by detection of light other than fluorescence of the compound in tissue. For example, reflectance of tissue can cause errors if proper correction is not made. In addition, the present invention may include various models related to fluorescence for measurement of tissue status and various methods of generating these models. Other biological information may be used in combination with fluorescence properties to aid in the determination of measurement of tissue status. The invention also includes devices suitable for carrying out the method, including suitable light sources, detectors, and models (eg, provided on a computer) used in connection with the measurement of the detected fluorescence and tissue state. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11490863-B2 |
| priorityDate | 2003-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 142.